ClinConnect ClinConnect Logo
Search / Trial NCT06587243

"Facts Tell… and With Stories Sell?" Combining Viewer-tailored Personal Human Papillomavirus (HPV) Narrative Video With HPV Vaccine Information Video to Improve HPV Vaccine Uptake

Launched by JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH · Sep 5, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Hpv Vaccine Narrative Communication Videos

ClinConnect Summary

This clinical trial is looking to find out the best way to encourage parents to get the HPV vaccine for their children aged 11 to 17. The study will compare three different types of videos: one that provides general information about the HPV vaccine, one that shares personal stories from people who have received the vaccine, and a combination of both types. By seeing which video works best, the researchers hope to improve the number of adolescents getting vaccinated against HPV, which can help prevent certain cancers.

To participate in this study, parents must have children between the ages of 11 and 17 who have not yet received the HPV vaccine. Unfortunately, parents whose children are already vaccinated will not be included. Participants will be asked to watch the videos and complete a survey about their experience. This study is not currently recruiting participants, but it aims to gather valuable insights on how to better communicate the importance of the HPV vaccine to families.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Parents of 11-17 year olds not yet vaccinated against HPV
  • Exclusion Criteria:
  • Parents whose adolescent children are already vaccinated against HPV
  • Participants who do not complete the survey
  • Participants who are unable or refuse to view and listen to videos on the participant's device

About Johns Hopkins Bloomberg School Of Public Health

The Johns Hopkins Bloomberg School of Public Health is a leading institution dedicated to advancing public health research and education. Renowned for its rigorous academic programs and commitment to improving global health outcomes, the School conducts innovative clinical trials that address pressing health challenges. With a focus on evidence-based practices, multidisciplinary collaboration, and community engagement, the Bloomberg School leverages its extensive resources and expertise to contribute to the development of effective public health interventions and policies. Through its research endeavors, the School aims to enhance population health and inform health policy both locally and globally.

Locations

Patients applied

0 patients applied

Trial Officials

Daniel Salmon, PhD

Principal Investigator

Johns Hopkins University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported